PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 10:27 AM ET

Sponsor Check › Person

JE
No photo found yet (own website and image search run after this page is viewed)

James Eadie

Named as an officer, director or promoter on SEC Form D filings · PA · Feb 27, 2019 → Apr 13, 2023

1deal (issuers)
$17.2Mreported sold
9investors
3Form D filings
2019–2023years on file

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:43 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

James Eadie is listed as a director on 3 SEC Form D filings by 1 issuer between Feb 2019 and Apr 2023: GENEOS Therapeutics, Inc. (Plymouth Meeting, PA — biotechnology — 2019–2023; $17.2M reported sold to 9 investors).

What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.

Listed alongside Casey Cunningham (3 shared filings), Niranjan Y. Sardesai (3 shared filings), J. Joseph Kim (2 shared filings), Samuel Broder (2 shared filings), Sangwoo Lee (2 shared filings) and 3 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around James. Each name links to their own page.

The issuer belongs to the sponsor group Inovio (2 issuers, $9.04M reported sold, 2019–2023).

What this means A sponsor group is one team that sets up a new company for each deal. Inovio has 2 companies on file and $9.04M reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — 1 bankruptcy case matching the name listed in Key records below.

What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 3 public filings for James Eadie and found 7 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "James Eadie" (A5) is a separate record; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for James Eadie has not run yet — it is joining a line of 54,433 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:43 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched James Eadie..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

1 case: 1 closed (disposition not in docket feed)

James T. Eadie and Aleathia Victoria P. Eadie closed
United States Bankruptcy Court, D. South Carolina · No. 95-70012 · Filed Jan 3, 1995 · Closed Feb 12, 1996
Role of James T. Eadie and Aleathia Victoria P. Eadie: Debtor · Outcome: Case closed 1996-02-12 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (rare in federal dockets); 5 people with this name in Form D filings; court in SC (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:43 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

7 differences found between the filings for James Eadie (compared 3 filings on Oct 24, 2026)

Note · Mar 31, 2023 – Apr 13, 2023

No amendment in the last 12 months on an offering that may still be open — GENEOS Therapeutics, Inc. (latest filing Apr 13, 2023)

The latest filing for this offering is dated Apr 13, 2023 (first sale Mar 31, 2023). It reports $4,999,998 sold of $9,999,996 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Nov 12, 2020 – Nov 17, 2020

No amendment in the last 12 months on an offering that may still be open — GENEOS Therapeutics, Inc. (latest filing Nov 17, 2020)

The latest filing for this offering is dated Nov 17, 2020 (first sale Nov 12, 2020). It reports $10,399,998 sold of $11,999,995 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · Feb 21, 2019 – Feb 27, 2019

No amendment in the last 12 months on an offering that may still be open — GENEOS Therapeutics, Inc. (latest filing Feb 27, 2019)

The latest filing for this offering is dated Feb 27, 2019 (first sale Feb 21, 2019). It reports $4,499,998 sold of $10,499,993 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Sources
Note · May 13, 2025 – Nov 3, 2025

Same name, different state: "James Eadie" (A5) is a separate record

This page covers filings where the address state is PA. A separate record, "James Eadie" with address state A5, is listed on 2 filings — most recently by ABK Biomedical Inc (Nov 3, 2025). The two records do not overlap in time: this page runs Feb 27, 2019 to Apr 13, 2023; the other runs May 13, 2025 to Nov 3, 2025.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Dec 6, 2018 – Aug 1, 2025

Same name, different state: "James Eadie" (MN) is a separate record

This page covers filings where the address state is PA. A separate record, "James Eadie" with address state MN, is listed on 4 filings — most recently by CryOSA, Inc. (Aug 1, 2025). Both records have filings in the same period (Feb 27, 2019 to Apr 13, 2023).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · May 25, 2021 – Aug 31, 2022

Same name, different state: "James Eadie" (FL) is a separate record

This page covers filings where the address state is PA. A separate record, "James Eadie" with address state FL, is listed on 2 filings — most recently by RAPIDPULSE, INC. (Aug 31, 2022). Both records have filings in the same period (May 25, 2021 to Aug 31, 2022).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
Note · Sep 5, 2014 – Aug 13, 2018

Same name, different state: "James Eadie" (CA or TX or MA) is a separate record

This page covers filings where the address state is PA. A separate record, "James Eadie" with address state CA or TX or MA, is listed on 15 filings — most recently by Reprieve Cardiovascular, Inc. (Jun 5, 2025). The two records do not overlap in time: this page runs Feb 27, 2019 to Apr 13, 2023; the other runs Sep 5, 2014 to Aug 13, 2018.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

1 of 3 offerings reports sales commissions totalling $50,000; 0 report finder's fees; 0 report proceeds to related persons.

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Apr 13, 2023 D
GENEOS Therapeutics, Inc.
File 021-478663
$0$0$0None listed on this filingEDGAR ↗
Nov 17, 2020 D
GENEOS Therapeutics, Inc.
File 021-380790
$0$0$0None listed on this filingEDGAR ↗
Feb 27, 2019 D
GENEOS Therapeutics, Inc.
File 021-333669
$50,000$0$0William B. Buchanan, Jr. BrokerCheck CRD 1048722 ↗
via CIM Securities, LLC (Brookline Capital Markets) (CRD 120852 ↗)

Andrew D. Daniels BrokerCheck CRD 2251612 ↗
via CIM Securities, LLC (Brookline Capital Markets) (CRD 120852 ↗)

Angela C. Dong BrokerCheck CRD 4367592 ↗
via CIM Securities, LLC (Brookline Capital Markets) (CRD 120852 ↗)

John Dexter Pearson BrokerCheck CRD 6093501 ↗
via CIM Securities, LLC (Brookline Capital Markets) (CRD 120852 ↗)

Scott A. Katzmann BrokerCheck CRD 1087840 ↗
via CIM Securities, LLC (Brookline Capital Markets) (CRD 120852 ↗)

Harris R.L. Lydon Jr. BrokerCheck CRD 1796845 ↗
via CIM Securities, LLC (Brookline Capital Markets) (CRD 120852 ↗)

Graham A Powis BrokerCheck CRD 2420999 ↗
via CIM Securities, LLC (Brookline Capital Markets) (CRD 120852 ↗)

Samuel P. Wertheimer BrokerCheck CRD 5984076 ↗
via CIM Securities, LLC (Brookline Capital Markets) (CRD 120852 ↗)

M.M.Dillon & Co., LLC BrokerCheck CRD 19878 ↗
via M.M. Dillon & Co., LLC (CRD 19878 ↗)
EDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 1

Every issuer that named James Eadie on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

Biotechnology · group: Inovio

GENEOS Therapeutics, Inc.

Plymouth Meeting, PA · Feb 27, 2019 → Apr 13, 2023 · 3 filings
  • Apr 13, 2023 · D · $4,999,998 sold of $9,999,996 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 17, 2020 · D · $10,399,998 sold of $11,999,995 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 27, 2019 · D · $4,499,998 sold of $10,499,993 · 3 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $17.2M from 9 investors (100% of the $10M target) as of the latest filing. James is listed as director on 3 filings for this deal.

Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other pages with the same name (4)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • James Eadie — CA, TX, MA, 6 issuers, Sep 5, 2014 → Aug 13, 2018 · no shared issuer
  • James Eadie — MN, 2 issuers, Dec 6, 2018 → Aug 1, 2025 · no shared issuer
  • James Eadie — Nova Scotia, Canada (as filed: A5), 1 issuer, May 13, 2025 → Nov 3, 2025 · no shared issuer
  • James Eadie — FL, 1 issuer, May 25, 2021 → Aug 31, 2022 · no shared issuer

People around James 8

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

CC
No photo found yet (own website and image search run after this page is viewed)
Person

Casey Cunningham

Director · 3 shared filings (1 issuer)

Listed on the same filings as James Eadie. Their page shows their other deals.

NS
No photo found yet (own website and image search run after this page is viewed)
Person

Niranjan Y. Sardesai

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as James Eadie. Their page shows their other deals.

JK
No photo found yet (own website and image search run after this page is viewed)
Person

J. Joseph Kim

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as James Eadie. Their page shows their other deals.

SB
No photo found yet (own website and image search run after this page is viewed)
Person

Samuel Broder

Director · 2 shared filings (1 issuer)

Listed on the same filings as James Eadie. Their page shows their other deals.

SL
No photo found yet (own website and image search run after this page is viewed)
Person

Sangwoo Lee

Director · 2 shared filings (1 issuer)

Listed on the same filings as James Eadie. Their page shows their other deals.

SB
No photo found yet (own website and image search run after this page is viewed)
Person

Samuel Dr. Broder

Director · 1 shared filing (1 issuer)

Listed on the same filings as James Eadie. Their page shows their other deals.

LH
No photo found yet (own website and image search run after this page is viewed)
Person

Laurent Humeau

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as James Eadie. Their page shows their other deals.

TF
No photo found yet (own website and image search run after this page is viewed)
Person

Ted Fjallman

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as James Eadie. Their page shows their other deals.

The team behind the deals

Sponsor group

Inovio

2 issuers · 6 filings · $9.04M reported sold · 2019–2023

One team, 2 deal companies. James Eadie is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name James Eadie.

Same business address

2 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

None of the 1 issuer this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to James Eadie by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 1 issuer this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers James Eadie is listed on: none on file. No website or social profile named in GENEOS Therapeutics, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #128,329 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Plymouth Meeting, PA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when James Eadie appears on a new Form D, or when a court case or SEC action is matched to them. See plans →